Radiofrequency Ablation
Radiofrequency Ablation
复制标题
DOI:
10.1007/978-1-84882-178-1_14
复制
发表时间:
2020-02
期刊:
影响因子:
--
通讯作者:
M. Trujillo;A. González-Suárez;R. Irastorza;Juan J. Pérez;E. Berjano
中科院分区:
文献类型:
--
作者:
M. Trujillo;A. González-Suárez;R. Irastorza;Juan J. Pérez;E. Berjano
Increasing use of sonography, computed tomography (CT), and magnetic resonance imaging (MRI) has led to a rapid rise in the discovery of small renal tumors and an increase in the detection of renal cell cancer (RCC). Although these incidentally discovered masses tend to be smaller and of lower grade than symptomatic lesions,1,2 the majority (65–80%) of these tumors are renal cell carcinomas (RCC) when pathologically analyzed.3 In addition, nearly 60% of these lesions will exhibit growth during active surveillance (mean 0.26 cm/year), such that given a long life expectancy, lesions in younger patients may grow sufficiently to become symptomatic or to metastasize.4